APA (7th ed.) Citation

SA, L., AL, K., PC, C., A, A., JR, S., GK, T., . . . A, H. (2026). Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial. Journal of the American Heart Association, 15(14), e047605. https://doi.org/10.1161/JAHA.125.047605

Chicago Style (17th ed.) Citation

SA, Luis, et al. "Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial." Journal of the American Heart Association 15, no. 14 (2026): e047605. https://doi.org/10.1161/JAHA.125.047605.

MLA (9th ed.) Citation

SA, Luis, et al. "Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial." Journal of the American Heart Association, vol. 15, no. 14, 2026, p. e047605, https://doi.org/10.1161/JAHA.125.047605.